Wazir Hina, Abid Marium, Essani Binish, Saeed Hira, Ahmad Khan Muhammad, Nasrullah Fnu, Qadeer Usama, Khalid Ayesha, Varrassi Giustino, Muzammil Muhammad Ali, Maryam Areeba, Syed Abdul Rehman Shah, Shah Abdul Ahad, Kinger Satish, Ullah Farhan
Internal Medicine, Khyber Medical College, Peshawar, PAK.
Medicine, Jinnah Medical and Dental College, Karachi, PAK.
Cureus. 2023 Dec 4;15(12):e49920. doi: 10.7759/cureus.49920. eCollection 2023 Dec.
This narrative review delves into the intricate landscape of liver diseases, providing a comprehensive background of the diverse conditions that afflict this vital organ. Liver diseases, ranging from viral hepatitis and non-alcoholic fatty liver disease (NAFLD) to cirrhosis and hepatocellular carcinoma (HCC), pose significant global health challenges. Understanding these diseases' multifaceted origins and progression is pivotal for developing effective diagnostic and therapeutic strategies. The epidemiology and etiology of liver diseases emphasize the global impact of viral hepatitis, with hepatitis B and C as significant contributors. Concurrently, the rising prevalence of NAFLD, linked to lifestyle factors and metabolic syndrome, underscores the intricate relationship between modern living and liver health. Chronic liver diseases often evolve insidiously, progressing from inflammation to fibrosis and, ultimately, to cirrhosis - a stage characterized by irreversible scarring and compromised function. The heightened risk of HCC in advanced liver disease stages further underscores the urgency of effective diagnostic and therapeutic interventions. The evolving landscape of non-invasive diagnostic tools is explored for their role in enabling early detection and accurate staging of liver diseases. In the realm of treatment, there is a continuous transition toward personalized medicine, customized to suit the unique profiles of individual patients. This shift encompasses a broad spectrum, ranging from personalized pharmacological interventions to lifestyle modifications and surgical options. Delving into innovative therapies, such as gene editing and immunomodulation, offers a glimpse into the promising future directions that have the potential to redefine the landscape of liver disease diagnosis and treatment.
这篇叙述性综述深入探讨了肝脏疾病的复杂领域,为困扰这一重要器官的各种病症提供了全面的背景信息。肝脏疾病范围广泛,从病毒性肝炎、非酒精性脂肪性肝病(NAFLD)到肝硬化和肝细胞癌(HCC),对全球健康构成了重大挑战。了解这些疾病多方面的起源和进展对于制定有效的诊断和治疗策略至关重要。肝脏疾病的流行病学和病因学强调了病毒性肝炎的全球影响,其中乙型和丙型肝炎是主要因素。与此同时,与生活方式因素和代谢综合征相关的NAFLD患病率不断上升,凸显了现代生活与肝脏健康之间的复杂关系。慢性肝病往往隐匿发展,从炎症发展为纤维化,最终发展为肝硬化——这一阶段的特征是不可逆转的瘢痕形成和功能受损。晚期肝病阶段HCC风险的增加进一步凸显了有效诊断和治疗干预措施的紧迫性。本文探讨了不断发展的非侵入性诊断工具在实现肝脏疾病早期检测和准确分期方面的作用。在治疗领域,正不断向个性化医疗转变,以适应个体患者的独特情况。这种转变涵盖范围广泛,从个性化药物干预到生活方式调整和手术选择。深入研究创新疗法,如基因编辑和免疫调节,让我们看到了有望重新定义肝脏疾病诊断和治疗格局的未来发展方向。